IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy (Q36167306)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy |
scientific article |
Statements
IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy (English)
1 reference
J M Wigginton
1 reference
E Gruys
1 reference
L Geiselhart
1 reference
J Subleski
1 reference
K L Komschlies
1 reference
J W Park
1 reference
T A Wiltrout
1 reference
K Nagashima
1 reference
T C Back
1 reference
R H Wiltrout
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference